12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Comparative Effectiveness of Smoking Cessation Medications: A National Prospective Cohort From Taiwan

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background and objective

          Relative effectiveness of smoking cessation medications—varenicline, bupropion and nicotine replacement therapy (NRT)—remains unclear among smokers in real-world settings. Evidence in females and smokers with light/moderate nicotine dependence is particularly insufficient. This study compared the effectiveness of varenicline, bupropion or NRT gum relative to NRT patch, in achieving abstinence among recent quitters.

          Methods

          In a national smoking cessation program in Taiwan (2012–2015), a cohort of 11,968 participants received varenicline (n = 5,052), bupropion (n = 823), NRT gum (n = 1944) or NRT patch (n = 4,149). The 7-day, 1-month or 6-month point-prevalence was calculated based on self-reported last smoking event via telephone interview after 6 months. Logistic regression modellings estimated odds ratios (OR) and 95% confidence intervals (CI) for achieving abstinence using different modalities (NRT patch as referent). Models included age, sex, education, marital status, geographic region, smoke-years, nicotine-dependence level, medical institution, number of clinic visits and medication use duration. Analyses were further stratified by sex and dependence severity.

          Results

          Participants were predominantly male (83%) with a mean age of 43.7±12.6 years. Varenicline users were more likely than NRT patch users to achieve abstinence, based on 7-day point-prevalence (OR = 1.30, CI: 1.19–1.44), 1-month point-prevalence (OR = 1.36, CI: 1.24–1.50) or 6-month point-prevalence (OR = 1.30, CI: 1.14–1.47). Compared with NRT patch, varenicline was associated with greater odds of being abstinent in women (OR = 1.29, CI: 1.01–1.65), men (OR = 1.31, CI: 1.18–1.46), those with light/moderate dependence (OR = 1.42, CI: 1.24–1.63) or smokers with severe dependence (OR = 1.19, CI: 1.04–1.37), based on 7-day point-prevalence. Differences in effectiveness were not observed between users of bupropion, NRT gum and NRT patch.

          Conclusions

          In smoking cessation clinics in Taiwan, varenicline users reported higher abstinence rates than NRT patch users after 6 months. Women and smokers with light/moderate nicotine dependence may also benefit from varenicline in actual clinical practice.

          Related collections

          Most cited references16

          • Record: found
          • Abstract: found
          • Article: not found

          21st-Century Hazards of Smoking and Benefits of Cessation in the United States

          Extrapolation from studies in the 1980s suggests that smoking causes 25% of deaths among women and men 35 to 69 years of age in the United States. Nationally representative measurements of the current risks of smoking and the benefits of cessation at various ages are unavailable. We obtained smoking and smoking-cessation histories from 113,752 women and 88,496 men 25 years of age or older who were interviewed between 1997 and 2004 in the U.S. National Health Interview Survey and related these data to the causes of deaths that occurred by December 31, 2006 (8236 deaths in women and 7479 in men). Hazard ratios for death among current smokers, as compared with those who had never smoked, were adjusted for age, educational level, adiposity, and alcohol consumption. For participants who were 25 to 79 years of age, the rate of death from any cause among current smokers was about three times that among those who had never smoked (hazard ratio for women, 3.0; 99% confidence interval [CI], 2.7 to 3.3; hazard ratio for men, 2.8; 99% CI, 2.4 to 3.1). Most of the excess mortality among smokers was due to neoplastic, vascular, respiratory, and other diseases that can be caused by smoking. The probability of surviving from 25 to 79 years of age was about twice as great in those who had never smoked as in current smokers (70% vs. 38% among women and 61% vs. 26% among men). Life expectancy was shortened by more than 10 years among the current smokers, as compared with those who had never smoked. Adults who had quit smoking at 25 to 34, 35 to 44, or 45 to 54 years of age gained about 10, 9, and 6 years of life, respectively, as compared with those who continued to smoke. Smokers lose at least one decade of life expectancy, as compared with those who have never smoked. Cessation before the age of 40 years reduces the risk of death associated with continued smoking by about 90%.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Sex differences in long-term smoking cessation rates due to nicotine patch.

            Compared to men, women may be at greater risk for smoking-related diseases and have greater difficulty quitting smoking. Sex differences in medication response could guide treatment for smoking cessation to improve women's quit rates. We conducted a meta-analysis of the 14 placebo-controlled nicotine patch trials (N = 6,250) for which long-term (6 months) clinical outcome results could be determined separately by sex. This analysis updated a meta-analysis of 11 of these trials that found no significant sex differences due to nicotine patch. The increase in quitting due to the nicotine vs. placebo patch was only about half as large in women as in men. Pooled absolute quit rates at 6 months for nicotine and placebo patch, respectively, were 20.1% and 10.8% in men, and 14.7% and 10.1% in women. The odds ratio for quitting due to nicotine vs. placebo patch was lower in women (OR = 1.61) than in men (OR = 2.20), with an interaction odds ratio of 1.40 (95% CI = 1.02-1.93, p = .04). This sex difference did not vary significantly by whether or not formal counseling was provided. Poorer outcomes in women vs. men treated with nicotine patch suggests that increasing the quit rates of women smokers may require supplementing patch treatment or use of other medications.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Adults, Including Pregnant Women: A Review of Reviews for the U.S. Preventive Services Task Force.

              Tobacco use is the leading cause of preventable death in the United States.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                PLoS One
                PLoS ONE
                plos
                plosone
                PLoS ONE
                Public Library of Science (San Francisco, CA USA )
                1932-6203
                28 November 2016
                2016
                : 11
                : 11
                : e0166992
                Affiliations
                [1 ]Department of Medicine, Stanford University School of Medicine, Stanford, California, United States of America
                [2 ]Institute of Health and Welfare Policy, National Yang-Ming University, Taipei, Taiwan
                [3 ]Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
                Centre for Addiction and Mental Health, CANADA
                Author notes

                Competing Interests: The authors have declared that no competing interests exist.

                • Conceptualization: PYC PCL KCH YWT.

                • Data curation: HCC.

                • Formal analysis: PCL HCC YWT.

                • Funding acquisition: KCH YWT.

                • Methodology: PYC PCL YWT.

                • Project administration: YWT.

                • Resources: KCH YWT.

                • Software: PCL HCC YWT.

                • Supervision: KCH YWT.

                • Validation: HCC YWT.

                • Visualization: PCL HCC.

                • Writing – original draft: PYC PCL.

                • Writing – review & editing: YWT.

                Article
                PONE-D-16-19187
                10.1371/journal.pone.0166992
                5125644
                27893843
                d236d6fa-fdf6-413a-a09a-6aeddc0158b9
                © 2016 Chang et al

                This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 11 May 2016
                : 7 November 2016
                Page count
                Figures: 2, Tables: 2, Pages: 13
                Funding
                Funded by: Health Promotion Administration, Taiwan
                Award ID: G1031227-105
                Award Recipient :
                Funded by: Health Promotion Administration, Taiwan
                Award ID: G1031227-105
                Award Recipient :
                Funded by: Health Promotion Administration, Taiwan
                Award ID: G1031227-105
                Award Recipient :
                Funded by: Health Promotion Administration, Taiwan
                Award ID: G1031227-105
                Award Recipient :
                National Yang-Ming University received research funding from the revenues of tobacco health and welfare surcharges by the Health Promotion Administration, Ministry of Health and Welfare, Taiwan, for project, titled “International Collaborative Project for the Evaluation of Medical Services for Smoking Cessation.” Yi-Wen Tsai (PI), Kuang-Chieh Hsueh (Co-PI), Po-Yin Chang, Po-Ching Lo and Hui-Chin Chang received grants (G1031227-105) from the Health Promotion Administration, Ministry of Health and Welfare, Taiwan ( http://www.hpa.gov.tw/BHPNet/English/Index.aspx). Health Promotion Administration, Taiwan provided data for the current study; it had no role in study design, analysis, data interpretation, or manuscript writing.
                Categories
                Research Article
                Medicine and Health Sciences
                Pharmaceutics
                Drug Therapy
                Neurological Drug Therapy
                Anti-Addiction Drug Therapy
                Nicotine Replacement Therapy
                Biology and Life Sciences
                Behavior
                Habits
                Smoking Habits
                Medicine and Health Sciences
                Pharmaceutics
                Drug Therapy
                People and Places
                Geographical Locations
                Asia
                Taiwan
                Research and Analysis Methods
                Research Design
                Clinical Research Design
                Comparative Effectiveness Research
                Social Sciences
                Sociology
                Education
                Schools
                Medicine and Health Sciences
                Health Care
                Health Care Facilities
                Outpatient Clinics
                Biology and Life Sciences
                Psychology
                Addiction
                Nicotine Addiction
                Social Sciences
                Psychology
                Addiction
                Nicotine Addiction
                Medicine and Health Sciences
                Mental Health and Psychiatry
                Substance-Related Disorders
                Nicotine Addiction
                Medicine and Health Sciences
                Public and Occupational Health
                Substance-Related Disorders
                Nicotine Addiction
                Custom metadata
                Health Promotion Administration, Taiwan provided data for the current study. Authors do not own the data. Data are available upon request to Health Promotion Administration, Ministry of Health and Welfare, Taiwan, for researchers who meet the criteria for access to confidential data. Interested readers may also contact Professor Yi-Wen Tsai to request the data set. Yi-Wen Tsai's email address: ywtsai@ 123456ym.edu.tw .

                Uncategorized
                Uncategorized

                Comments

                Comment on this article